Business Description
Marizyme Inc
NAICS : 325412
SIC : 2834
ISIN : US5703721028
Description
Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. Currently, the company is focused on developing three medical technology products: DuraGraft, Krillase, and MATLOC. DuraGraft is a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure, MATLOC is a point-of-care, lab-on-chip digital screening, and diagnostic device platform, initially being developed for quantitative chronic kidney disease, or CKD, assessment, and Krillase protein enzyme provides a therapeutics opportunity for wound healing, thrombosis, and pet health.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -0.6 | |||||
| Debt-to-Equity | -0.98 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -11.8 | |||||
| Beneish M-Score | -6.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -152 | |||||
| 3-Year EPS without NRI Growth Rate | -98.3 | |||||
| 3-Year FCF Growth Rate | -253.9 | |||||
| 3-Year Book Growth Rate | -33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.92 | |||||
| 9-Day RSI | 66.21 | |||||
| 14-Day RSI | 58.61 | |||||
| 6-1 Month Momentum % | -47.22 | |||||
| 12-1 Month Momentum % | -26.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.02 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 383.68 | |||||
| Days Sales Outstanding | 41.43 | |||||
| Days Payable | 3528.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.8 | |||||
| Shareholder Yield % | -222.56 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.62 | |||||
| Operating Margin % | -2354.39 | |||||
| Net Margin % | -13369.09 | |||||
| FCF Margin % | -854.22 | |||||
| ROE % | -671.61 | |||||
| ROA % | -184.41 | |||||
| ROIC % | -24.94 | |||||
| ROC (Joel Greenblatt) % | -3828.09 | |||||
| ROCE % | -209.26 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.31 | |||||
| EV-to-EBIT | -0.46 | |||||
| EV-to-EBITDA | -0.47 | |||||
| EV-to-Revenue | 43.17 | |||||
| EV-to-FCF | -5.05 | |||||
| Earnings Yield (Greenblatt) % | -217.39 | |||||
| FCF Yield % | -114.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MRZM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Marizyme Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.592 | ||
| EPS (TTM) ($) | -1.83 | ||
| Beta | -0.47 | ||
| Volatility % | 121.24 | ||
| 14-Day RSI | 58.61 | ||
| 14-Day ATR ($) | 0.005233 | ||
| 20-Day SMA ($) | 0.080025 | ||
| 12-1 Month Momentum % | -26.58 | ||
| 52-Week Range ($) | 0.05 - 0.405 | ||
| Shares Outstanding (Mil) | 46.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Marizyme Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Marizyme Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Marizyme Inc Frequently Asked Questions
What is Marizyme Inc(MRZM)'s stock price today?
The current price of MRZM is $0.10. The 52 week high of MRZM is $0.41 and 52 week low is $0.05.
When is next earnings date of Marizyme Inc(MRZM)?
The next earnings date of Marizyme Inc(MRZM) is 2024-05-15 Est..
Does Marizyme Inc(MRZM) pay dividends? If so, how much?
Marizyme Inc(MRZM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers